MYRIAD GENETICS INC Quarterly Deferred Income Tax Expense (Benefit) in USD from Q3 2010 to Q3 2011
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Myriad Genetics Inc annual/quarterly Deferred Income Tax Expense (Benefit) history and growth rate from Q3 2010 to Q3 2011.
- Myriad Genetics Inc Deferred Income Tax Expense (Benefit) for the quarter ending September 30, 2011 was -$14.8M, a 17.9% decline year-over-year.
- Myriad Genetics Inc annual Deferred Income Tax Expense (Benefit) for 2023 was -$4.3M, a 85.9% increase from 2022.
- Myriad Genetics Inc annual Deferred Income Tax Expense (Benefit) for 2022 was -$30.5M, a 3.79% increase from 2021.
- Myriad Genetics Inc annual Deferred Income Tax Expense (Benefit) for 2021 was -$31.7M, a 43.1% increase from 2020.
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), YoY Quarterly Growth (%)